A Real-World Study of COVID-19 Infection in Patients With Malignant Lymphomas Participating in Clinical Trials
Sponsor
Sun Yat-sen University (Other)
Overall Status
Completed
CT.gov ID
NCT05827341
Collaborator
(none)
133
1
2
66.4
Study Details
Study Description
Brief Summary
This study focuses on the population of malignant lymphoma patients who are also in clinical research. Through a real world cross-sectional survey of infection and death risk during the COVID-19 pandemic in Guangzhou from December 2022 to January 2023, this study aims to clarify the risk, level and mortality of lymphoma patients infected with COVID-19 during their clinical research, and provide necessary research data for Chinese lymphoma patients during the COVID-19 pandemic,
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Study Design
Study Type:
Observational
Actual Enrollment
:
133 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
A Real-World Study of COVID-19 Infection in Patients With Malignant Lymphomas Participating in Clinical Trials
Actual Study Start Date
:
Dec 1, 2022
Actual Primary Completion Date
:
Jan 31, 2023
Actual Study Completion Date
:
Jan 31, 2023
Outcome Measures
Primary Outcome Measures
- Moderate/Severe COVID-19 infection rate [2 months]
The percentage of moderate/severe COVID-19 infection in maligant lymphoma patients
- Hospital admission rate of COVID-19 infection [2 months]
The percentage of malignant lymphoma patients who were admitted into hospital
Eligibility Criteria
Criteria
Ages Eligible for Study:
0 Years
to 99 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- All malignant lymphoma patients participating in clinical trials in Sun Yat-Sen University cancer center Those were identifed as COVID-19 infection.
Exclusion Criteria:
- Patients who could not provide detailed information about COVID-19 infection.
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Department of Medical Oncology, Sun Yat-Sen University Cancer Center | Guangzhou | Guangdong | China | 510060 |
Sponsors and Collaborators
- Sun Yat-sen University
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Li Zhiming,
Prof.,
Sun Yat-sen University
ClinicalTrials.gov Identifier:
NCT05827341
Other Study ID Numbers:
- B2023-075-01
First Posted:
Apr 25, 2023
Last Update Posted:
Apr 25, 2023
Last Verified:
Feb 1, 2023